Journal of the Neurological Sciences
Volume 194, Issue 1 , Pages 21-28 , 15 February 2002

GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats

  • W Zhang

      Affiliations

    • Department of Pathology, Wayne State University, 540 E. Canfield Ave., Detroit, MI 48201, USA
    • Morris Hood Jr. Comprehensive Diabetes Center, Wayne State University, Detroit, MI, USA
    • ,
  • B Slusher

      Affiliations

    • Guilford Pharmaceutical Inc., Baltimore, MD, USA
    • ,
  • Y Murakawa

      Affiliations

    • Department of Pathology, Wayne State University, 540 E. Canfield Ave., Detroit, MI 48201, USA
    • Morris Hood Jr. Comprehensive Diabetes Center, Wayne State University, Detroit, MI, USA
    • ,
  • K.M Wozniak

      Affiliations

    • Guilford Pharmaceutical Inc., Baltimore, MD, USA
    • ,
  • T Tsukamoto

      Affiliations

    • Guilford Pharmaceutical Inc., Baltimore, MD, USA
    • ,
  • P.F Jackson

      Affiliations

    • Guilford Pharmaceutical Inc., Baltimore, MD, USA
    • ,
  • A.A.F Sima

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Pathology, Wayne State University, 540 E. Canfield Ave., Detroit, MI 48201, USA. Tel.: +1-313-577-1150; fax: +1-313-577-0057
    • Department of Pathology, Wayne State University, 540 E. Canfield Ave., Detroit, MI 48201, USA
    • Department of Neurology, Wayne State University, Detroit, MI, USA
    • Morris Hood Jr. Comprehensive Diabetes Center, Wayne State University, Detroit, MI, USA

Received 8 June 2001 ,Revised 25 September 2001 ,Accepted 5 November 2001.

References 

  1. Sima AAF, Sugimoto K. Experimental diabetic neuropathy—an update. Diabetologia. 1999;42:773–788
  2. Cameron NE, Cotter MA. In:  Sima AAF editors. Chronic complications in diabetes. Oxidative stress and abnormal lipid metabolism in diabetic complication. Frontiers in animal diabetes research. vol. 1:Amsterdam: Harwood Acad. Publ; 2000;p. 97–130
  3. Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilatation in arterioles that overlie the sciatic nerve. Int. J. Exp. Diabetes Res. 2000;1:131–143
  4. Srinivasan S, Stevens M, Wiley JW. Diabetic neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes. 2000;49:1932–1938
  5. Fagg GE, Foster AC. Excitatory amino acid synaptic mechanisms and neurological function. Trends Pharmacol. Sci. 1986;7:357–363
  6. Butcher SP, Bullock R, Graham DI, McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 1990;21:1727–1733
  7. Brown B, Yoo Y-MM, Wozniak K, Hartman T, Slusher BS. NAALADase inhibition attenuates hyperalgesia in formalin- and acetic acid-induced models of acute pain. Soc. Neurosci. 1999;25:2230
  8. Berger UV, Schwab ME. N-acetylated alpha-linked acidic dipeptidase may be involved in axon Schwann cell signaling. J. Neurocytol. 1996;25:499–512
  9. Yao Y-M, Moulhardt E, Slusher BS. Inhibition of NAALADase activity promotes myelin formation following mouse sciatic nerve cryo-lesion. Soc. Neurosci. 1997;23:2302
  10. Jackson PF, Cole DC, Slusher BS, Stetzt SL, Ross LE, Donzanti BA, et al.  Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated-α-linked acidic dipeptidase. J. Med. Chem. 1996;39:619–622
  11. Slusher BS, Vornov JJ, Thomas AG, Hurn PD, Harukuni I, Bhardwaj A, et al.  Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 1999;5:1396–1402
  12. Corse AM, Thomas AG, Coccia CF, Rothstein JD, Slusher BS. NAALADase inhibition protects motor neurons against chronic glutamate toxicity. Soc. Neurosci. 1997;23:2301
  13. Wozniak KM, Callizot N, Poindron P, Slusher BS. NAALADase inhibition enhances behavioral and morphological recovery following sciatic nerve crush in mice. Soc. Neurosci. 2000;26:111
  14. Sugimoto K, Murakawa Y, Sima AAF. Diabetic neuropathy—a continuing enigma. Diabetes Metab. Res. Rev. 2000;16:408–433
  15. Sima AAF, Zhang W, Xu G, Sugimoto K, Guberski D, York MA. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. Diabetologia. 2000;43:787–793
  16. Hargreaves KM, Dubuer R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88
  17. Sima AAF, Zhang W, Sugimoto K, Henry D, Wahren J, Grunberger G. C-peptide prevents and improves chronic type 1 diabetic polyneuropathy in the BB/Wor rat. Diabetologia. 2001;44:889–897
  18. Sima AAF, Blaivas M. In:  Garcia JH,  Budka H,  McKeever PE,  Sima AAF editor. Neuropathology, the diagnostic approach. Peripheral neuropathies. Philadelphia: Mosby; 1997;p. 765–809
  19. Sima AAF. Neuropathic and ocular complications in the BB-Wistar rat. In:  Shafrir E,  Renold A editor. Lessons from animal diabetes. London: John Libbey's; 1984;p. 447–453
  20. Yagahashi S, Sima AAF. Diabetic autonomic neuropathy. The distribution of structural changes in sympathetic nerves of the BB rat. Am. J. Pathol. 1985;121:138–147
  21. Wroblewski B, Wroblewski JT, Pschenichkin S, Surin A, Sullivan SE, Neoli JH. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 1997;69:1116–1119
  22. Bruno V, Battaglia G, Copani A, Giffard RG, Raciti G, Raffacle R, et al.  Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 1995;7:1906–1913
  23. Kawamata M, Omote K. Involvement of increased excitatory amino acids and intracellular Ca2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain. 1996;68:85–96
  24. Bordi F, Quartaroli M. Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus. Pain. 2000;84:213–223
  25. Malcangio M, Tomlinson DR. A pharmacological analysis of mechanical hyperalgesia in streptozotocin diabetic rats. Pain. 1998;76:151–157
  26. Burchiel KJ, Russel LC, Lee RP, Sima AAF. Spontaneous activity of primary afferent neurons in diabetic BB-Wistar rats. A possible mechanism of chronic diabetic pain. Diabetes. 1985;34:1210–1213
  27. Hall KE, Sima AAF, Wiley JW. Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurons from the BB/W diabetic rat. J. Physiol. (London). 1995;486:313–322
  28. Thayer SA, Wang GJ. Glutamate-induced calcium loads: effects on energy metabolism and neuronal viability. Clin. Exp. Pharmacol. Physiol. 1995;22:303–304
  29. White BC, Sullivan JM, DeGarcia DJ, O'Neil BJ, Neumar RW, Grossman KI, et al.  Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 2000;179:1–33
  30. Stevens EJ, Carrington AL, Tomlinson DR. Nerve ischemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia. 1994;37:43–48
  31. Krause GS, White BC, Aust SD, Nayini NR, Kumar K. Brain cell death following ischemia and reperfusion: a proposed biochemical sequence. Crit. Care Med. 1998;16:714–726
  32. Cooper HK, Zalewska T, Kawakani S, Hossman KA. The effect of ischemia and recirculation on protein synthesis in the rat brain. J. Neurochem. 1977;28:929–934
  33. Greene DA, Stevens MJ, Obrosova I, Feldman EL. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur. J. Pharmacol. 1999;375:217–223
  34. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of dl-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy. Diabetes. 2000;49:1006–1015
  35. Russell JW, Sullivan KA, Windebank AJ, Hermann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol. Dis. 1999;6:347–363
  36. Gong C, Berent A, Golovoy D, Slusher B, Russell JW. Inhibition of NAALADase protects neurons against glucose-induced programmed cell death models of diabetic neuropathy. Soc. Neurosci. 2000;26:605

PII: S0022-510X(01)00670-0

Journal of the Neurological Sciences
Volume 194, Issue 1 , Pages 21-28 , 15 February 2002

Article Tools

* Image Usage & Resolution